Form 4/A for SYK Stryker Corporation
Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-31 · accession 0000310764-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MAI | 2025-02-04 | 2025-01-31 | SYK | STRYKER RONDA E | Dir, 10% | S - Sale | $392.75 | -236.0K | 3.68M | -6% | -$92.69M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | S | D | 96,728 | $390.89 | 3,746,739 | I By Revocable Trust | — | — | (F1) This amendment is being filed to correct the number of shares sold (and applicable transaction prices) on January 31, 2025. (F2) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $390.39 to $391.38, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| 2 | Common | Common Stock | 2025-01-31 | S | D | 38,802 | $391.89 | 3,707,937 | I By Revocable Trust | — | — | (F1) This amendment is being filed to correct the number of shares sold (and applicable transaction prices) on January 31, 2025. (F3) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $391.385 to $392.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| 3 | Common | Common Stock | 2025-01-31 | S | D | 7,462 | $392.69 | 3,700,475 | I By Revocable Trust | — | — | (F1) This amendment is being filed to correct the number of shares sold (and applicable transaction prices) on January 31, 2025. (F4) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $392.38 to $393.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| 4 | Common | Common Stock | 2025-01-31 | S | D | 12,213 | $396.69 | 3,607,467 | I By Revocable Trust | — | — | (F1) This amendment is being filed to correct the number of shares sold (and applicable transaction prices) on January 31, 2025. (F8) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $396.39 to $397.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| 5 | Common | Common Stock | 2025-01-31 | S | D | 51,454 | $394.85 | 3,630,738 | I By Revocable Trust | — | — | (F1) This amendment is being filed to correct the number of shares sold (and applicable transaction prices) on January 31, 2025. (F6) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $394.38 to $395.37, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| 6 | Common | Common Stock | 2025-01-31 | S | D | 11,058 | $395.90 | 3,619,680 | I By Revocable Trust | — | — | (F1) This amendment is being filed to correct the number of shares sold (and applicable transaction prices) on January 31, 2025. (F7) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $395.39 to $396.385, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| 7 | Common | Common Stock | 2025-01-31 | S | D | 18,283 | $393.97 | 3,682,192 | I By Revocable Trust | — | — | (F1) This amendment is being filed to correct the number of shares sold (and applicable transaction prices) on January 31, 2025. (F5) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $393.38 to $394.375, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |